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INVESTIGATION

Mutational Analysis of Sse1 (Hsp110) Suggests an
Integral Role for this Chaperone in Yeast Prion
Propagation In Vivo
Ciara Moran,* Gemma K. Kinsella,† Zai-Rong Zhang,‡,1 Sarah Perrett,‡ and Gary W. Jones*,2

*Yeast Genetics Laboratory and †The Marie Curie Laboratory for Membrane Proteins, Department of Biology, National
University of Ireland Maynooth, Maynooth, County Kildare, Ireland, and ‡National Laboratory of Biomacromolecules,
Institute of Biophysics, Chinese Academy of Sciences, Chaoyang District, Beijing 100101, China

ABSTRACT The yeast Hsp110 chaperone Sse1 is a conserved protein that is a noncanonical member of the
Hsp70 protein superfamily. Sse1 inﬂuences the cellular response to heat stress and has also been implicated
in playing a role in the propagation of prions in yeast. Sse1 can seemingly exert its effects in vivo through
direct or indirect actions by inﬂuencing the nucleotide exchange activity of canonical cytosolic Hsp70s.
Using a genetic screen based on the inability to propagate the yeast [PSI+] prion, we have identiﬁed 13 new
Sse1 mutants that are predicted to alter chaperone function through a variety of different mechanisms. Not
only are these new Sse1 mutants altered in the ability to propagate and cure yeast prions but also to varying
degrees in the ability to grow at elevated temperatures. The expression levels of chaperone proteins known
to inﬂuence yeast prion propagation are unaltered in the Sse1 mutants, suggesting that the observed
phenotypic effects are caused by direct functional alterations in these mutants. Mapping the location of
the mutants onto the Sse1 crystal structure suggests that more than one functional alteration in Sse1 may
result in changes in prion propagation and ability to function at elevated temperatures. All Sse1 mutants
isolated provide essential functions in the cell under normal growth conditions, further demonstrating that
essential chaperone functions in vivo can to some degree at least be detached from those related to
propagation of prions. Our results suggest that Sse1 can inﬂuence prion propagation through a variety
of different mechanisms.

Hsp110 proteins are a group of eukaryotic molecular chaperones that
have been implicated in a variety of cellular functions. Several cytosolic
Hsp110 protein variants have been described in eukaryotes, including
HSPH1, Apg-1, Apg-2, and Grp170 in mammals (Vos et al. 2008;
Kampinga et al. 2009). Hsp110 is represented in Saccharomyces cerevisiae by the Sse1 and Sse2 proteins. SSE1 and SSE2 constitute an
essential gene pair in yeast (Trott et al. 2005) and although not essential
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in itself deletion of SSE1 does confer a growth defect and stressrelated phenotypes (Shirayama et al. 1993; Shaner et al. 2004, 2008).
Sse1 was ﬁrst isolated from yeast biochemically as a calmodulinbinding protein (Mukai et al. 1993) and genetically as a suppressor
of a protein kinase A (PKA) mutant (Shirayama et al. 1993). Sse1
and Sse2 share a high degree of sequence identity (~76%) and are
noncanonical members of the Hsp70 superfamily (Mukai et al.
1993). SSE1 is expressed at moderately high levels under normal growth
conditions and is further induced upon heat shock whereas SSE2 transcripts are nearly undetectable at basal temperatures but are increased
more than 20-fold upon heat shock (Mukai et al. 1993; Shirayama
et al. 1993).
The Sse1 protein has been crystallized and established to be modular, built-up from Hsp70-like subdomains (Liu and Hendrickson
2007). Although Sse1 and canonical Hsp70 have diverged in function,
certain structural features in Hsp70 have been conserved in Sse1.
Mutational analysis revealed that particular mutant variants of Sse1
and Ssa1 (one of the major yeast cytosolic Hsp70s) result in similar
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phenotypic defects, supporting the hypothesis that Sse1 is an evolutionary vestige of Hsp70 (Liu and Hendrickson 2007). It has been
reported that Sse1, like Ssa1, can recognize and bind hydrophobic
peptide sequences with high afﬁnity (Goeckeler et al. 2008) and can
exhibit ATPase activity (Raviol et al. 2006a,b). However, the functional similarities end there, as Sse1 cannot functionally refold denatured proteins but instead acts as a “holdase” by binding denatured
proteins and preventing their aggregation (Oh et al. 1999). This “holdase” function may serve a function in the peptide-refolding pathway
carried out by other chaperones. Various Hsp110 homologs have been
shown to accelerate the refolding of luciferase by Hsp70/Hsp40 machinery (Goeckeler et al. 2002).
Although speciﬁc intracellular functions of Hsp110 proteins are
poorly characterized in comparison with various canonical Hsp70s, it
has been suggested recently that they may act as the principal nucleotide
exchange factor (NEF) for Hsp70. Sse1 was shown to act as a potent
NEF for yeast cytosolic Hsp70 proteins Ssa1 and Ssa2 (Dragovic et al.
2006; Raviol et al. 2006b). This discovery followed soon after the discovery that Hsp110 proteins physically and functionally interact with
their Hsp70-Ssa counterparts (Yamagishi et al. 2004; Shaner et al. 2005;
Yam et al. 2005). Prior to these ﬁndings Fes1 was the only identiﬁed
NEF for Ssa1 (Kabani et al. 2002a). The regulation of substrate binding
by ATP hydrolysis and subsequent nucleotide exchange is a key component in maintaining correct in vivo function for all Hsp70 chaperones.
The general domain organization of Sse1 does reﬂect that of canonical Hsp70s. It consists of a N-terminal nucleotide-binding domain (NBD), a b-sandwich domain (SBD-b) and a three helical
bundle domain (3HBD or SBD-a) toward the C-terminus. The Sse1
protein has a compact structure with tight interactions between the
NBD and substrate-binding domain (SBD). Unlike Hsp70, the Sse1
SBD-a does not form a lid over its binding pocket but instead interacts with the ﬂank of the Sse1 NBD (Polier et al. 2008). Sse1 is larger
than Hsp70 as the result of insertions within the SBD and a C-terminal
extension (Easton et al. 2000; Liu and Hendrickson 2007). Sse1 shares
~30% sequence identity with Ssa1 (Shaner et al. 2005; Yam et al. 2005).
Like other Hsp70-Hsp110 interacting components, the sequence similarity between Sse1 and Ssa1 is largely conﬁned to the NBD (Goeckeler
et al. 2008).
Sse1 preferentially associates with Ssa1 in vivo (Shaner et al. 2005).
The Hsp70 NBD is embraced by the NBD and SBD-a of Sse1, leading
to the opening of the Hsp70 nucleotide-binding cleft. The Sse1
b-sandwich domain of the substrate binding cleft alternates away
from the complex (Polier et al. 2010). It appears that almost the entire
length of Sse1 is required for complex formation with Hsp70 (Shaner
et al. 2004; Dragovic et al. 2006; Polier et al. 2008). Complex formation also requires Sse1 to be ATP-bound as this alters the NBD
structure in a way that stabilizes it and allows it to bind Hsp70 (Shaner
et al. 2006; Polier et al. 2008). Yeast Sse1 can also form a functional
complex with human Hsp70, which reﬂects a high degree of conservation in the Hsp70-Hsp110 structure (Shaner et al. 2006).
The multidomain architecture of Sse1 suggests that it may play
a role as a chaperone similar to Hsp70. However, the protein folding
ability of canonical Hsp70s relies heavily on the conformational structural changes between the NBD and SBD upon ATP/ADP binding;
such allostery appears absent in Sse1. The Sse1 substrate-binding
pocket remains closed upon ATP binding, suggesting that any potential substrate-binding or chaperone activity inherent in Sse1 will be
functionally distinct to Hsp70 (Andréasson et al. 2008).
Since the seminal paper by Wickner (1994), who proposed that the
yeast non-Mendelian genetic elements [PSI+] and [URE3] are prions
of the Sup35 and Ure2 proteins, respectively, the authors of many
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subsequent studies have shown this proposal to be correct and that
a signiﬁcant number of other fungal proteins have prion forming
ability (Derkatch et al. 2001; Alberti et al. 2009). A variety of
in vitro and in vivo studies have demonstrated an integral role for
molecular chaperones in yeast prion propagation (reviewed in, Jones
and Tuite 2005; True 2006; Perrett and Jones 2008; Masison et al.
2009). Most chaperone/prion studies have focused upon the yeast
Hsp40/Hsp70/Hsp104 protein disaggregation machinery (Chernoff
et al. 1995; Glover et al. 1997; Krzewska and Melki 2006; Shorter
and Lindquist 2008), which has been shown to play an essential role
in propagation of yeast prions. More recently, evidence has accumulated
suggesting a role for yeast Hsp110 in prion formation and propagation.
Studies have demonstrated Sse1 may be required for the de novo formation and propagation of [PSI+] (Fan et al. 2007; Kryndushkin and
Wickner 2007; Sadlish et al. 2008). Current understanding suggests
that Sse1 primarily inﬂuences prion formation and propagation due
to its NEF function for Hsp70; however, Sse1 has been suggested to
bind to early intermediates in Sup35 prion conversion and thus facilitate prion seed conversion independently of its NEF function (Sadlish
et al. 2008). Overexpressed Sse1 was shown to increase the rate of
de novo [PSI+] formation while deleting SSE1 reduced [PSI+] prion
formation; however, no effects on pre-existing [PSI+] were observed
(Fan et al. 2007; Kryndushkin and Wickner 2007). In contrast, the
overproduction or deletion of SSE1 cured the [URE3] prion and mutant analysis suggests this activity is dependent on ATP binding and
interaction with Hsp70 (Kryndushkin and Wickner 2007). Intriguingly, Sse1 has recently been shown to function as part of a protein
disaggregation system that appears to be conserved in mammalian
cells (Shorter 2011; Duennwald et al. 2012).
To gain further insight into the possible functional roles of Hsp110
in prion propagation, we have isolated an array of novel Sse1 mutations that differentially impair the ability to propagate [PSI+]. The
locations of these mutants on the Sse1 protein structure suggest that
impairment of prion propagation by Hsp110 can occur through a number of independent and distinct mechanisms. The data suggests that
Sse1 can inﬂuence prion propagation not only indirectly through an
Hsp70-dependent NEF activity, but also through a direct mechanism
that may involve direct interaction between Sse1 and prion substrates.
MATERIALS AND METHODS
Strains and plasmids
Strains and plasmids used and constructed in this study are listed
and described in Table 1 and Table 2. Site-directed mutagenesis
using the Quickchange kit (Stratagene) and appropriate primers
were used to introduce desired mutations into plasmids. The G600
strain, the genome of which was recently sequenced (Fitzpatrick et al.
2011), was used to amplify SSE genes via polymerase chain reaction
for cloning into pRS315. The human HSPH1 gene (alternative name
HSP105) was ampliﬁed from a cDNA clone purchased from Origene
(Rockville, MD). All plasmids constructed in this study were veriﬁed
by sequencing.
Media and genetic methods
Standard media was used throughout this study as previously described (Guthrie and Fink 1991). Monitoring of [PSI+] was carried out
as described (Jones and Masison 2003). Brieﬂy, the presence of [PSI+]
(the non-functional aggregated form of Sup35) and SUQ5 causes efﬁcient translation read through of the ochre mutation in the ade2-1
allele. Non-suppressed ade2-1 mutants are Ade- and are red when
grown on medium containing limiting amounts of adenine due to

n Table 1 Strains used in this study
Strain name
G600
HLY100
HLY101
HLY102
CMY02
Y02146
Y17167
CMY01

CMY03
SB34

Genotype

Source
[PSI+]

MATa ade2.1 SUQ5 kar1-1 his3 leu2 trp1 ura3
G600 plus Dsse1
G600 mating type switched plus Dsse2
G600 isogenic +/Dsse1 +/Dsse2 [PSI+] diploid. Constructed by mating
HLY100 and HLY101 and transforming with pRS316-SSE1
G600 plus Dsse1 Dsse2 pRS316-SSE1, isolated as haploid segregant
following sporulation of HLY102
MATa his3D1 leu2D0 met15D0 ura3D0 sse1::KanMX4
MATa his3D1 leu2D0 lys2D0 ura3D0 sse2::KanMX4
MATa/a his3D1/his3D1 leu2D0/leu2D0 lys2D0/+ +/met15D0 ura3D0
+/sse1::KanMX4 sse2::KanMX4/+ pRS316-SSE1 (constructed by
mating Y02146 with Y17167 and transforming with pRS316-SSE1)
MATa his3D1 leu2D0 lys2D0 ura3D0 sse1::KanMX4 sse2::KanMX4
pRS316-SSE1 (haploid segregant following sporulation of CMY01)
MATa trp1-1 ade2-1 leu2-3,112 his3-11,15 ura2::HIS3 erg6::TRP1 dal5::
ADE2 [URE3]

Jones et al. (2004)
This study
This study
This study
This study
Euroscarf
Euroscarf
This study

This study
Bach et al. (2003)

SSE1 mutants that could weaken [PSI+]. Transformation plates were
replica plated onto medium-containing limiting amounts of adenine
and also 5-ﬂuoro-orotic acid, a chemical that selects against URA+
cells and hence against the presence of the pRS316-SSE1 plasmid.
Colonies appearing red or dark-pink at this stage were scored as potentially harboring a mutant sse1 allele that cannot maintain [PSI+]. All
potential sse1 mutant containing plasmids were isolated and retransformed back into CMY02 and analyzed for their effects upon [PSI+].
After retransformation, the color phenotype of colonies was scored
subjectively from 0 to 9, with 0 being white and 9 being red (Loovers
et al. 2007).

the accumulation of a pigmented substrate of Ade2. Partial suppression of ade2-1 by [PSI+] allows growth without adenine and
eliminates the pigmentation (Cox 1965).
Monitoring of [URE3] again made use of the red/white selection
based on the ADE2 gene. The strain SB34 has ADE2 under control of
the DAL5 promoter. In [URE3] cells expression of the DAL5 promoter
is high because of the action of Gln3. In [ure-0] cells soluble Ure2 can
interact with Gln3 and prevent transcription from the DAL5 promoter. Hence, when [URE3] is present the SB34 strain will grow on
medium lacking adenine and is white on medium with limiting adenine. When [ure-0] this strain will not grow on medium lacking
adenine and is red on medium with limiting adenine.

Assaying mutant effects on [URE3]
Effects on [URE3] were assayed as previously described (Loovers et al.
2007). To summarize, SB34 was grown to log phase growth under
conditions that maintain [URE3] (medium lacking adenine). Cells
were transformed with wild-type (WT) or mutant SSE1 alleles and
transformants were selected on medium lacking leucine. At this stage
all cells (at least 100) were scored for color phenotype on the basis of
being white, red or sectored.

Generation of SSE1 mutant library
Plasmid pRS315-SSE1 was subjected to treatment with hydroxylamine
for 60 min (Schatz et al. 1988). This treatment resulted in mutation
frequencies of around 8% for this plasmid (G. W. Jones, unpublished
data).
Isolation of Sse1 mutants that impair [PSI+]
prion propagation
Sse1 mutants were isolated using the plasmid shufﬂe technique. Strain
CMY02 was transformed with the SSE1 mutagenized plasmid library.
Transformed cells were selected on medium lacking leucine. Any red
or dark-pink colonies were scored at this point as potential dominant

Mapping mutants onto crystal structure of Sse1 and
molecular modeling
Structures for Sse1 (2QXL; (Liu and Hendrickson 2007) and for Sse1
in complex with Ssa1 (3D2F; (Polier et al. 2008) were obtained from

n Table 2 Plasmids used in this study
Plasmid Name
pRS315
pRS316
pRS423
pC210
pRS315-SSE1
pRS316-SSE1
pRS315-SSE2
pRS315-SSE2Q504E
pRS315-SSE2G616D
pRS315-SSE2Q504E/G616D
pRS423-FES1
pC-HSPH1
pRS423-CIA1

Description

Source

Centromeric Saccharomyces cerevisiae shuttle vector, LEU2 marker
Centromeric Saccharomyces cerevisiae shuttle vector, URA3 marker
2m Saccharomyces cerevisiae high copy plasmid, HIS3 marker
SSA1 under control of SSA2 promoter, LEU2 marker
SSE1 6 500bp cloned into pRS315, LEU2 marker
SSE1 6 500bp cloned into pRS315, URA3 marker
SSE2 6 500bp cloned into pRS315, LEU2 marker
Site directed mutagenesis of pRS315-SSE2 to produce Q504E
Site directed mutagenesis of pRS315-SSE2 to produce G616D
Site directed mutagenesis of pRS315-SSE2Q504E to produce
Q504E+G616D
FES1 6500bp cloned into pRS423, HIS3 marker
HSPH1 under control of SSA2 promoter, LEU2 marker
CIA1 6 500bp cloned into pRS423, HIS3 marker

(Sikorski and Hieter 1989)
(Sikorski and Hieter 1989)
(Christianson et al. 1992)
(Schwimmer and Masison 2002)
This study
This study
This study
This study
This study
This study
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the Protein Data Bank. Molecular modeling to complete gap regions,
introduce point mutations (100 models each), and for visualization
was carried out using Molecular Operating Environment, version
2009.10 (Chemical Computing Group Inc., 2009). Images were generated using pyMol (DeLano 2002).
Western analysis
Western analysis was performed essentially as described previously
(Jones and Masison 2003). Hsp70 monoclonal antibody was purchased from Cambridge Bioscience (SPA822), Sse1 polyclonal antibody was a gift from Jeff Brodsky (University of Pittsburgh), and
Hsp104 polyclonal antibody was a gift from John Glover (University
of Toronto).
RESULTS
Isolation of novel mutants of SSE1 that impair [PSI+]
prion propagation
Applying the plasmid shufﬂe technique as described in Materials and
Methods we have identiﬁed 13 new mutants of Sse1 that impair propagation of the [PSI+] prion (Figure 1, Table 3). Nine of these mutants
are located in the NBD and like previous studies highlight the general
functional importance of correct ATPase regulation of Hsp70 chaperones in yeast prion propagation (Jones and Masison 2003; Loovers
et al. 2007). The mutants had a wide range of effects on propagation of
[PSI+], with some being unable to propagate the prion at all (G41D,
G50D, D236N, G342D, E370K, and G616D) to others having minor
effects on color phenotype (P37L, C211Y; Table 3 and Figure 1B). The
presence or absence of [PSI+] in all mutants was conﬁrmed by mating
with a [psi2] strain followed by sporulation of any [PSI+] diploids to
conﬁrm non-Mendelian segregation and subsequent growth on guanidine hydrochloride to cure the prion (data not shown). As expected,
all Sse1 mutants that could not propagate [PSI+] could not grow on
medium lacking adenine (Figure 1B). However, surprisingly, all other
Sse1 mutants, even ones that had an apparently mild affect on [PSI+],
also grew very poorly or not at all on medium lacking adenine (Figure
1B). The reason for these growth results is unknown but perhaps
suggests Sse1 may be involved in cellular metabolic pathways that
can result in complex nutritional phenotypes. Signiﬁcantly, none of

the mutants had a major adverse effect on cell growth at 30°, suggesting that each mutant is capable of carrying out the essential cellular
functions of Sse1 (Table 3). However, at 39° there are major differences in the abilities of the mutants to grow (Table 3, Figure 1B).
Deletion of SSE1 causes a 39° temperature-sensitive phenotype (Shaner et al. 2008) and therefore it appears that a subset of mutants
(G50D, G342D, S440L, G616D) are effectively nonfunctional at this
elevated temperature. Other mutants appear to provide either WT
levels of activity (P37L, T365I, E554K) or some intermediate or reduced level of Sse1 functionality (G41D, C211Y, D236N, G343D,
E370K, E504K).
Effects of FES1 overexpression on the ability of Sse1
mutants to propagate [PSI+]
Both Fes1 and Sse1 have been shown to be NEFs for cytosolic Hsp70s
(Kabani et al. 2002b; Dragovic et al. 2006; Raviol et al. 2006b) We
therefore assessed the ability of Fes1 to complement the prion propagation defect of this novel set of Sse1 mutants. To do this we carried
out plasmid shufﬂe analysis for each Sse1 mutant in the presence of
over-expressed Fes1 (Figure 2). As a negative control plasmid shufﬂe
analysis was also carried out in the presence of either pRS423 (vector
only) or pRS423 harboring the CIA1 gene 6500 bp. CIA1 is a yeast
gene that has not been implicated in altering yeast prion propagation.
After growth on 5-ﬂuoro-orotic acid media also lacking histidine (to
maintain selection for pRS423 based plasmids), cells were placed onto
YPD to assess color and –ADE –HIS medium to assess the ability to
grow on medium lacking adenine. Although the color phenotype on
YPD for Sse1 WT or mutant cells harboring the vector or overexpressing FES1 is consistent with presence of Sse1 alone (compare Figure 1B
YPD panel with Figure 2 control and FES1 YPD panels), the ability of
some CMY02 Sse1 mutant cells to grow on medium lacking adenine is
inﬂuenced greatly by the absence of histidine (compare Figure 1B
–ADE panel with Figure 2 control and FES1 –ADE panels). Only
G616D appears altered in color on YPD by the presence of FES1
overexpression. However, this color change does not correlate with
a signiﬁcant increased ability to grow on –ADE medium (Figure 2).
Comparing the effects of vector only to overexpressed FES1, a clear
difference in ability to grow on –ADE medium is observed for some
mutants; P37L, C211Y, S440L, and E554K grow less well on –ADE in

Figure 1 (A) Sse1 mutants that
impair prion propagation are
located in various domains of
the protein. Numbers above
refer to amino acids that deﬁne the boundaries of the nucleotide-binding domain (NDB),
linker region (L), substratebinding domain (SBD), Hsp110
insertion region (I), and Hsp110
extension region (E). Mutants
isolated that impair prion propagation are indicated below
the linear structure. (B) Phenotype of Sse1 mutants that
impair prion propagation. Top
panel shows color on YPD, middle panel depicts growth on
medium lacking adenine, and
bottom panel is growth on YPD
at 39°.
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n Table 3 Relative effects of SSE1 mutants on [PSI+] prion propagation and cell growth
Sse1 Mutation
None
P37L
G41D
G50D
C211Y
D236N
G342D
G343D
T365I
E370K
S440L
E504K
E554K
G616D

Times Isolateda

Color Pre-5-FOAb

Color post-5-FOAb

Growth at 39°c

Generation time (% of WT)d

2
1
3
3
1
1
3
1
1
1
1
1
2
1

0
2
3
4
3
4
3
3
3
2
2
2
3
2

0
3
8
8
2
9
9
4
5
9
6
4
4
9

+++++
+++++
++
+
++
++
2
+++
+++++
+++
+
+++
+++++
2

100
96
100
101
93
110
114
104
104
107
97
118
101
113

5-FOA, 5-ﬂuoro-orotic acid; WT, wild type.
a
Number of independent times isolated in the mutant screen.
b
Color: 0, white [PSI+]; nine, Red, [psi-]; FOA, selection against presence of WT SSA1 URA3 plasmid.
c
Relative growth after 2 d at 39°.
d
Doubling time in minutes expressed as a % of CMY02 harboring WT SSE1.

the presence of overexpressed FES1, whereas G343D and T365I grow
slightly better in the presence of overexpressed FES1 (Figure 2), suggests that increases in Hsp70 (Ssa) NEF activity are able to inﬂuence
some phenotypes of this subset of Sse1 mutants. Currently, we have
no explanation for the complex but reproducible –ADE phenotype of
these novel Sse1 mutants shown in Figures 1B and 2.
Sse1 mutants are defective in ability to cure
[URE3] prion
A previous study has highlighted the ability of overexpressed Sse1 to
impair propagation of the yeast prion [URE3] (Kryndushkin and
Wickner 2007). Similarly we found that in the SB34 strain background
(Bach et al. 2003) the introduction of an extra copy of SSE1 under
control of its native promoter was capable of causing a signiﬁcant
impairment of [URE3] (Table 4). We therefore assessed the ability
of the Sse1 mutants to impair [URE3] propagation using this assay. In
contrast to WT Sse1 and in contrast to the diverse phenotypic effects
observed in [PSI+] prion propagation and temperature sensitivity
assays, we found that all thirteen novel Sse1 mutants were unable to
signiﬁcantly impair [URE3] propagation in the SB34 strain (Table 4).

This suggests either a common functional change or defect within these
mutants with respect to the ability to cure [URE3] or that more than
one functional alteration in Sse1 can impair [URE3] curing ability.
Chaperone abundance in Sse1 mutants
It is well documented that certain chaperones play an essential role in
prion maintenance and alteration in expression levels can affect [PSI+]
propagation (for review see (Jones and Tuite 2005)). We therefore
measured Sse1, Hsp104 and the Hsp70 (Ssa) chaperone family expression levels in all the Sse1 mutants. Figure 3 (and data not shown)
shows that no major differences in chaperone expression levels exist
between any mutants compared to wild-type Sse1. Only the P37L
mutant appeared to have slightly increased levels of Hsp104 and
Ssa, but taking into account previous ﬁndings these are unlikely to
be the cause of any prion or temperature-related phenotypes (Jung
et al. 2000; Jones and Masison 2003; Loovers et al. 2007). In addition
we also measured levels of Hsp70 co-chaperones Ydj1 and Sis1 and
found similar amounts of these Hsp40s within the Sse1 mutants analyzed in Figure 3 compared to wild type (data not shown). Therefore,
the phenotypic changes in prion propagation and growth at high

Figure 2 Sse1 mutants exhibit
a complex growth phenotype
when grown on medium lacking adenine. The absence of
histidine and the presence of
FES1 can affect the ability
of Sse1 mutants to grow on medium lacking adenine. Top section is growth in presence of
either vector control or overexpression of CIA1, and bottom
section is in the presence of
over-expressed FES1. The results shown are representative
of three independent experiments, for controls this constitutes two experiments with
vector only and one with CIA1
overexpression.
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n Table 4 Relative effects of Sse1 mutants on ability
to cure [URE3]
Sse1 Mutation

% White

% Red

% Sectored

48
90
96
94
92
98
95
84
84
94
87
87
86
83
96

13
3
1
4
4
1
2
7
11
2
5
4
4
4
2

39
7
3
2
5
1
3
9
5
4
8
9
10
13
2

None/WT
P37L
G41D
G50D
C211Y
D236N
G342D
G343D
T365I
E370K
S440L
E504K
E554K
G616D
Vector only

Colony color was scored subjectively as for Table 1. Colony percentage is given
after transformation of SSE1 mutant into SB34 as described in Materials and
Methods. WT, wild type.

temperatures observed in these novel Sse1 mutants is most likely not
due to indirect changes in chaperone expression levels.
As shown in Figure 1, a number of Sse1 mutants are unable to
grow at 39°. One possible explanation for this phenotype is that such
Sse1 mutants are unstable at this temperature. We therefore used
Western blotting to assess the stability of Sse1 mutants following
exposure to 39° for 1 hr and found no difference in stability between
any Sse1 mutants compared to wild-type protein (data not shown).
Location of mutants on crystal structure of Sse1:
functional implications
The crystal structure of the Sse1 protein alone and in complex with
cytosolic Hsp70 has been determined (Liu and Hendrickson 2007;
Polier et al. 2008; Schuermann et al. 2008). To gain insight into
possible functional consequences of this new set of Sse1 mutations
we mapped mutated residues onto available Sse1 structures and used
molecular modeling to predict possible localized structural changes and
functional implications (Figure 4, Table 5 and Supporting Information,
File S1). Of the nine mutants identiﬁed within the NBD four are
predicted to affect ATP binding (P37L, G342D, G343D, E370K), three
to alter interaction with cytosolic Hsp70 (G41D, T365I, E370K), and
three remain unclear (G50D, C211Y, D236N) (Table 5, File S1). The
four mutants isolated in the SBD domain are predicted to alter either
Sse1 interaction with cytosolic Hsp70 (E554K, G616D, see Figure S3),
substrate binding (S440L), or protein2protein interactions (E504K)
(Table 5 and Supplemental Information).
Sse2 and [PSI+] propagation
Figure S1 shows an alignment of Sse1 and Sse2. Although these proteins share 76% identity, Sse2 is unable to compensate for Sse1 in
terms of [PSI+] prion propagation or growth at higher temperatures
(Figure 5; Sadlish et al. 2008; Shaner et al. 2008). All but one of our
novel Sse1 mutated residues is conserved in Sse2, the nonconserved
residue corresponding to position E504 in Sse1, which is Q504 in Sse2.
We reasoned that the inability of Sse2 to propagate [PSI+] could be
inﬂuenced by this residue difference. Using site-directed mutagenesis,
we created a Q504E mutant version of Sse2 and assessed the ability of
this protein to propagate [PSI+]. In contrast to wild-type Sse2,
Sse2Q504E is able to propagate [PSI+], although not to the same degree
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Figure 3 No change in protein levels of chaperones known to alter
[PSI+] propagation in Sse1 mutants. Western blot analysis to measure
protein levels of Sse1, Hsp70 (Ssa), and Hsp104. After initial blotting
with anti-Sse1 antisera, the membrane was stripped and subsequently
probed with Hsp104 and Hsp70 antibodies. The membrane was
stained with Amido Black to show loading.

as Sse1 (Figure 5). Interestingly, although [PSI+] propagation is restored to some degree in Sse2Q504E, the ability to grow at 39° is not
(Figure 5). In addition to rendering Sse1 unable to propagate [PSI+],
the G616D mutation was one of two Sse1 mutants that also caused
a 37° temperature-sensitive phenotype (Figure 5 and data not shown).
Similarly, when G616D is introduced into Sse2 the same phenotype
was observed, indicating conservation of functional importance of this
residue in these two proteins. Combining Q504E and G616D in the
Sse2 protein produces similar phenotypes as observed for Sse1 (Figure
5) and further demonstrates the functional conservation between
these residues within yeast Sse proteins.
Functional complementation of an sse1 sse2 double
deletion strain by FES1 and human HSPH1 is dependent
on strain background
A previous study has reported that the essential and prion-related
functions of Sse1 were mainly related to the ability of the protein to
function as a NEF for Hsp70. This was demonstrated by the ability of
Fes1 and a N-terminally truncated Snl1 protein to complement the
lethality of an sse1 sse2 double deletion strain (Sadlish et al. 2008). We
therefore assessed whether Fes1 and the closest human Sse1 ortholog
HSPH1 (Figure S2) could propagate [PSI+] in the G600 background.
We found that both Fes1 and HSPH1 were unable to complement
essential Sse1/2 functions in the CMY02 strain (Figure 6), and hence
we were unable to assess whether [PSI+] could be propagated. The inability of Fes1 and HSPH1 to functionally substitute for deletion of sse1
and sse2 is strain speciﬁc as both were able to provide essential Sse1/2
functions in strain CMY03, which was constructed in the BY4741
background (Figure 6, Table 1). The cause of this difference in strain
complementation is as yet unknown.
DISCUSSION
We have identiﬁed 13 novel mutations in Sse1 that have varying
effects on both the ability of S. cerevisiae to propagate the [PSI+] prion
and also to grow at increased temperatures. In contrast, all Sse1
mutants were similarly impaired in the ability to cure the [URE3]
prion following overexpression. The phenotypic effects of these
mutants appear to result from functional changes in the Sse1 protein
and are not due to changes in expression levels of other chaperones
known to inﬂuence prion propagation. Given the varied locations of
these mutants in the Sse1 molecule and their predicted structural
effects, we provide evidence to suggest that Sse1 can inﬂuence both

Figure 4 Mapping of mutations onto Sse1 structure. (A) Structural
model of Sse1 (PDB: 2QXL) with the residues of interest highlighted
and in ball and stick format. Domains are colored to correspond to
Figure 1A. Images were generated using Pymol (DeLano 2002).

yeast prion propagation and heat shock response in a variety of ways,
which are potentially direct or indirect in manner.
Recently, Sse1 has been shown to play a role in the disaggregation
of amyloid aggregates, including Sup35 (Shorter 2011; Rampelt et al.
2012). In combination with Hsp40 and Hsp70, Sse1 can dissolve
amyloid aggregates albeit at a slower rate than Hsp104. Sse1 also
can enhance disaggregation by Hsp104 (in the presence of Hsp40
and 70). This new role for Hsp110 proteins is conserved across species
and provides the ﬁrst clearly identiﬁed protein disaggregation machinery in mammalian cells (Shorter 2011; Duennwald et al. 2012). This
newly discovered biochemical activity of Sse1 and the fact that Sse1
appears to interact directly with Sup35 prions in vivo (Bagriantsev
et al. 2008) suggests that this chaperone may play a more direct and
active role in modulating the propagation of yeast prions than was previously thought. Sse1 may inﬂuence prion propagation through inﬂuencing Ssa1 function but may also do so through interacting directly
with prion aggregates. The diverse range of Sse1 mutants we have
isolated in this genetic screen and their potential functional implications
(Table 5 and Supplemental Information), supports this proposal.
Phenotypic analysis of the Sse1 mutants revealed subsets of mutants that were impaired to varying degrees in their ability to grow at
elevated temperatures (Figure 1, Table 3). These results were very
clear-cut and presumably are a consequence of altered Sse1 function
due to the structural alterations. However, [PSI+] and corresponding
adenine growth phenotypes of the mutants was very complex (Figure
1 and Figure 2, Table 3). The colony color phenotype initially used for
screening and assessing the presence of [PSI+] was very clear; that is to

say, the presence or absence of [PSI+] correlated well with the colony
color phenotype. In contrast, the ability to grow on medium lacking
adenine did not correlate well for all the mutants. As expected those
mutants shown not to propagate [PSI+] did not grow on –ADE medium. However, some Sse1 mutants conﬁrmed as maintaining [PSI+]
were also unable to grow on medium lacking adenine. Furthermore,
the removal of histidine from the medium can inﬂuence the ability of
some Sse1 mutants to grow in the absence of adenine and the subsequent overexpression of FES1 can further affect this phenotype (Figure 2). Currently, we do not have any explanation for this very complex
but reproducible phenotype, but speculate that Sse1 may play a role
(direct or indirect) in modulating the histidine and/or adenine biosynthetic pathways. Both pathways are part of the “super-pathway of
histidine, purine and pyrimidine biosynthesis” (Saccharomyces Genome
Database) and converge on production of the biosynthetic intermediate
aminoimidazole carboxamide ribonucleotide, accumulation of which
can be toxic to the cell. If Sse1 is involved in modulating this superpathway then our mutants may be affected in the ability to synthesize
either histidine or adenine (or both) and toxic intermediates on this
pathway may also be caused to accumulate. The addition of histidine or
adenine to growth medium would have the effect of switching off these
pathways and therefore suppressing any impaired growth phenotype
due to the accumulation of toxic intermediates.
Given the variation in the effects of mutants upon [PSI+] propagation and also heat shock we were surprised to discover that all the
Sse1 mutants were unable to efﬁciently cure the [URE3] prion. In
a previous study, Kryndushkin and Wickner (2007) demonstrated that
overexpression of the Sse1G223D mutant (reduction in Sse1 ATPase,
interaction with Ssa1 and loss of Ssa1 NEF activity) was unable to cure
[URE3] whereas Sse1K69M (can bind ATP but defective in hydrolysis)
efﬁciently cured [URE3]. Thus, it seemed that efﬁcient Sse1 NEF
activity is required to cure [URE3]. Our data suggest that this may
be an oversimpliﬁcation. The clear phenotypic differences observed
for the Sse1 mutants in respect of [PSI+] propagation and heat shock
cannot be explained by a single unifying change in Sse1 function in all
mutants. This suggestion is also supported by the location of the
mutations on the Sse1 structure. Therefore it appears that a variety
of mechanisms that alter Sse1 function can alter the ability to cure
[URE3]. However, it should be noted that the ability to cure [URE3]
could be inﬂuenced by the prion variant that is present in the cells.
The [URE3] variants present in the SB34 strain and strains used by
Kryndushkin and Wickner (2007) have not been compared directly.
Although Sse1 and Sse2 share a high degree of amino acid sequence identity (Figure S1), Sse2 is unable to compensate fully for
the loss of Sse1. Sse2 has previously been shown to compensate for all
sse1-deﬁcient phenotypes at 30° (Shaner et al. 2004); however, this is
not the case for [PSI+] propagation (Figure 5). In the G600 strain
background, the loss of Sse1 function causes loss of [PSI+], demonstrating a clear distinction in the activities of Sse1 and Sse2 at 30°. The
fact that the Sse1 mutants that have the greatest impairment of [PSI+]
propagation are predicted to be altered in ATP binding and interaction with Hsp70 suggests that in vivo these activities are where Sse1
and Sse2 will differ the most. However, of all 13 mutated residues
isolated in Sse1 identiﬁed as altering prion propagation, only one
(E504) is not conserved in Sse2 (Q504) (Figure S1). We reasoned that
this residue contributes to the inability of Sse2 to propagate [PSI+].
When this residue is mutated to create Sse2Q504E [PSI+] can be propagated albeit not to the same extent as Sse1 (Figure 5). This result
suggests that this residue is a key factor in dictating divergence of Sse1
and Sse2 function, and this residue is not predicted to alter ATPbinding or interaction with Hsp70. Hence, it appears that the in vivo
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n Table 5 Predicted structural effects of mutants
Mutation
P37L
G41D
G50D
C211Y
D236N
G342D
G343D
T365I
E370K
S440L
E504K
E554K
G616D

Location

Predicted Effect

b-sheet within NBD
b-sheet within NBD
a-helix within NBD
b-sheet within NBD
a-helix within NBD
ATP binding pocket of NBD
ATP binding pocket of NBD
Loop region within NBD
a-helix within NBD
a-helix within SBDb
Within insertion region of SBDb
a-helix within SBDa
Loop region within SBDa

ATP binding
Hsp70 interaction
Unclear
Unclear
Unclear
ATP binding
ATP binding
Hsp70 interaction
ATP binding/Hsp70 interaction
Substrate binding
Protein-protein interactions
Protein-protein interactions
Hsp70 interaction

NBD, nucleotide-binding domain; SBD, substrate binding domain.

differences in function between Sse1 and Sse2 are probably attributable
to a number of different modiﬁcations in activity and not solely to one
distinct difference. Clearly the interaction with Hsp70 is a key factor for
in vivo function of Sse1 and Sse2 as demonstrated by the conserved
effects of the G616D mutation (Figure 5). The combining of the Q504E
and G616D mutation in the Sse2 protein produces similar phenotypic
responses as for the same Sse1 variant. This indicates the functional
conservation of these residues in yeast Sse proteins.
The conservation of essential in vivo functions carried out
by Sse1 is clearly shown by the ability of the closest human homolog HSPH1 to complement the growth phenotype of a sse1 sse2
deletion strain. A recently characterized Hsp110 ortholog from
Arabidopsis thaliana (AtHsp70-15) was shown to be unable to
complement heat shock phenotypes of a sse1 deletion strain constructed in the W303 background (Jungkunz et al. 2011). The G600
background used in this study is currently the most closely related
sequenced laboratory strain to the original reference yeast strain
S288C (Fitzpatrick et al. 2011) and yet there is a background-speciﬁc

effect on the ability of HSPH1 to complement Sse defects. Hence,
testing the AtHsp70-15 cDNA for complementation of sse deletion
strains in different yeast backgrounds is certainly worth investigating
and may demonstrate further the conservation of Hsp110 essential
functions across diverse species.
The isolation of a set of new Sse1 mutants that alter yeast prion
propagation has provided further evidence of an integral role for this
chaperone in modulating the propagation of [PSI+] and perhaps the
growing list of conﬁrmed yeast prions. This set of newly characterized
Sse1 mutants provides the opportunity for detailed biochemical assessment to address the causes of subtle differences that may exist in
the functional alterations of Sse1 that effect activities in prion propagation as compared to other roles in heat shock or stress resistance.
The canonical Hsp70 (Ssa) family is well characterized in its ability to
modulate prion propagation and how this function can be distinct
from roles in the heat shock response (Jung et al. 2000; Jones and
Masison 2003; Loovers et al. 2007). To some degree, the same may be
true for Sse1.

Figure 5 Phenotypic analysis of
yeast cells expressing Sse2 as
the sole source of Hsp110.
Growth of Sse1, Sse2, and
Sse2 derived mutants on medium lacking adenine (top
growth panels) and at elevated
temperature (lower growth panels). Western blotting was used
to assess expression levels of
Sse1, Sse2, and mutants (bottom panels).
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Figure 6 Complementation of sse1 sse2 deletion strain by overexpression of FES1 or mammalian HSPH1. Growth of sse1 sse2 expressing FES1 or HSPH1 in place of SSE1 was assessed in two strain
backgrounds; CMY02 (G600 background, left section) and CMY03
(BY background, right section). As expected, vector only control produced no growth in either background.
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